Click to Share
 

Biosimilars Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

12666016
By SMi Group
SMi Group has announced that Mr John Carlsen, Vice President at Covance, has joined the speaker line-up for the 4th annual Biosimilars North America conference which takes place on November 15 & 16 in New Jersey.
12663339
By SMi Group
Biosimilars and Biobetters 2017 attendee list released featuring the Alliance For Safe Biologic Medicines, Boehringer Ingelheim, Celltrion, Gan & Lee Pharmaceuticals, Gedeon Richter Ltd, QuintilesIMS, Samsung Bioepis and Teva
By SMi Group
Industry Leaders Set to Gather in Central London at 8th Annual Biosimilars European Summit
By SMi Group
As the biosimilars market continues to grow, it is important to understand the regulatory hurdles that come with drug development, patent application, approval and launch.
12659017
By SMi Group
Oncobiologics, developers and manufacturers of complex biosimilar therapeutics, will be presenting two exclusive sessions at SMi Group's 4th annual Biosimilars North America conference in New Jersey this November.
12658782
By SMi Group
Mishcon de Reya present on the role of competition and IP law for Biosimilars at 8th annual industry meeting
By SMi Group
SMi Group has announced that Mr Patrick Lucy, CEO of Pfenex, has joined the speaker line-up for the 4th annual Biosimilars North America conference which takes place on November 15 & 16 in New Jersey.
By American Conference Institute
The U.S. Supreme Court recently overturned the Federal Circuit and held that a patentee is not allowed to impose any post-sale restrictions for use of the patented product and that the patentee's rights are exhausted once a product is sold anywhere in...
12638417
By American Conference Institute
American Conference Institute is proud to announce its 8th Annual Summit on Biosimilars, which will be held June 12-14, 2017 in New York City.
12579199
By SMi Group
SMi are delighted to have Duncan Emerton from FirstWord present at the 7th Annual Biosimilars Europe when it returns to London on 29TH-30TH September 2016.

All Press Releases

By SMi Group
SMi Reports: An exclusive interview with Anita Burrell, Founder & CEO at Anita Burrell Consulting and speaker at this year's 5th annual Biosimilars USA conference, is now available to download on the event website.
By SMi
SMi Group Reports: Following the FDA's release of a Biosimilar Action Plan, this year's Biosimilars USA conference promises to explore the developments in biosimilar drug development
By SMi Group
SMi Reports: An exclusive interview with Dr Michel Mikhail, an independent consultant and chairman of this year's Biosimilars & Biobetters conference, is now available to download on the event website.
By SMi Group
SMi Reports: Registration for SMi's 9th annual Biosimilars and Biobetters conference has opened and the brochure is available to download
By SMi Group
SMi Group Reports: The official agenda for the 5th annual Biosimilars USA conference, which is taking place this fall in New Jersey, USA, has been released.
12666016
By SMi Group
SMi Group has announced that Mr John Carlsen, Vice President at Covance, has joined the speaker line-up for the 4th annual Biosimilars North America conference which takes place on November 15 & 16 in New Jersey.
12663339
By SMi Group
Biosimilars and Biobetters 2017 attendee list released featuring the Alliance For Safe Biologic Medicines, Boehringer Ingelheim, Celltrion, Gan & Lee Pharmaceuticals, Gedeon Richter Ltd, QuintilesIMS, Samsung Bioepis and Teva
By SMi Group
Industry Leaders Set to Gather in Central London at 8th Annual Biosimilars European Summit
By SMi Group
As the biosimilars market continues to grow, it is important to understand the regulatory hurdles that come with drug development, patent application, approval and launch.
12659017
By SMi Group
Oncobiologics, developers and manufacturers of complex biosimilar therapeutics, will be presenting two exclusive sessions at SMi Group's 4th annual Biosimilars North America conference in New Jersey this November.
12658782
By SMi Group
Mishcon de Reya present on the role of competition and IP law for Biosimilars at 8th annual industry meeting
By SMi Group
SMi Group has announced that Mr Patrick Lucy, CEO of Pfenex, has joined the speaker line-up for the 4th annual Biosimilars North America conference which takes place on November 15 & 16 in New Jersey.
By Visiongain
Visiongain's new report Global Biosimilar Monoclonal Antibodies Forecast 2017-2027: Biosimilar Versions of Infliximab, Rituximab, Trastuzumab, Adalimumab, Bevacizumab and Abciximab indicates that the global biosimilar monoclonal antibodies market will...
By visiongain
Visiongain's new report Global Biosimilars and Follow-On Biologics Market 2017-2027: Monoclonal Antibodies (mAbs), Fusion Proteins, Insulin, Erythropoietins, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Growth Hormones, Fertility Hormones..
By SMi Group
SMi Group has announced that Dr Cindy Cao, Executive Director and Head of US Regulatory Affairs for Biopharmaceuticals at Sandoz has joined the speaker panel for the 4th Biosimilars North America, which takes place on November 15 & 16, 2017.
By SMi Group
Building on the success of previous events, SMi has announced the return of its 4th annual Biosimilars North America Conference, taking place on November 15 and 16, 2017 in Iselin, New Jersey.
By American Conference Institute
The U.S. Supreme Court recently overturned the Federal Circuit and held that a patentee is not allowed to impose any post-sale restrictions for use of the patented product and that the patentee's rights are exhausted once a product is sold anywhere in...
12638417
By American Conference Institute
American Conference Institute is proud to announce its 8th Annual Summit on Biosimilars, which will be held June 12-14, 2017 in New York City.
By Sen. John Kuehn
32nd State to allow innovative class of pharmaceuticals provide life-saving treatments for cancer, rheumatoid arthritis, and diabetes
By Nebraska Biosimilars
Innovative class of pharmaceuticals provide life-saving treatments for cancer, rheumatoid arthritis, and diabetes
12579199
By SMi Group
SMi are delighted to have Duncan Emerton from FirstWord present at the 7th Annual Biosimilars Europe when it returns to London on 29TH-30TH September 2016.

Page: 1 Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share